Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies

Dose Finding, Efficacy and Safety of BI 655064 in Patients With Active Lupus Nephritis

Zoster Eye Disease Study

To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine

An Exploratory Maintenance Trial of BI 655064 in Patients With Lupus Nephritis

Entyvio (Vedolizumab) Long Term Safety Study

A Study of Idasanutlin With Cytarabine Versus Cytarabine Plus Placebo in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)

A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease

A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis

An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)

Strategy to Prevent the Onset of Clinically-Apparent Rheumatoid Arthritis

Stereotactic Laser Ablation for Temporal Lobe Epilepsy

An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease

Omega-3 Replacement With Krill Oil in Disease Management of SLE

Treatments Against RA and Effect on FDG-PET/CT

An Extension Study of Omalizumab in Participants With Chronic Rhinosinusitis With Nasal Polyps

A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus

Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease

A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE)

A Study of Lasmiditan (LY573144) Over Four Migraine Attacks